Barr, Mylan Receive Favorable Ruling in Mirapex Challenge

Drug Industry Daily
A A
Barr Laboratories and Mylan Pharmaceuticals have prevailed in a patent infringement case involving generic versions of Boehringer Ingelheim’s Parkinson’s disease drug Mirapex.

To View This Article:

Login

Subscribe To Drug Industry Daily